Cite
A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson's Disease in Clinical Practice: An International Study.
MLA
Quattrone, Andrea, et al. “A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson’s Disease in Clinical Practice: An International Study.” Movement Disorders, vol. 36, no. 3, Mar. 2021, pp. 681–89. EBSCOhost, https://doi.org/10.1002/mds.28364.
APA
Quattrone, A., Antonini, A., Vaillancourt, D. E., Seppi, K., Ceravolo, R., Strafella, A. P., Morelli, M., Nigro, S., Vescio, B., Bianco, M. G., Vasta, R., Arcuri, P. P., Weis, L., Fiorenzato, E., Biundo, R., Burciu, R. G., Krismer, F., McFarland, N. R., Mueller, C., & Gizewski, E. R. (2021). A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson’s Disease in Clinical Practice: An International Study. Movement Disorders, 36(3), 681–689. https://doi.org/10.1002/mds.28364
Chicago
Quattrone, Andrea, Angelo Antonini, David E. Vaillancourt, Klaus Seppi, Roberto Ceravolo, Antonio P. Strafella, Maurizio Morelli, et al. 2021. “A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson’s Disease in Clinical Practice: An International Study.” Movement Disorders 36 (3): 681–89. doi:10.1002/mds.28364.